CLINICAL_TRIALS
trial_result
· 2012-09-24
Clinical Trial Update: Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating paclitaxel for patients with refractory or recurrent endometrial cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED